Jahnson S - Search Results

1

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer.

Holmberg L, Hagberg O, Häggström C, Gårdmark T, Ströck V, Aljabery F, Jahnson S, Hosseini A, Jerlström T, Sherif A, Söderkvist K, Ullén A, Enlund M, Liedberg F, Malmström PU. Holmberg L, et al. Among authors: jahnson s. PLoS One. 2022 Sep 23;17(9):e0274859. doi: 10.1371/journal.pone.0274859. eCollection 2022. PLoS One. 2022. PMID: 36149914 Free PMC article.

2

Extent of blood transfusion and cancer-related mortality after cystectomy and urinary diversion for bladder cancer.

Jahnson S, Bergström R, Pedersen J. Jahnson S, et al. Br J Urol. 1994 Dec;74(6):779-84. doi: 10.1111/j.1464-410x.1994.tb07125.x. Br J Urol. 1994. PMID: 7827851

3

A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma.

Lundholm C, Norlén BJ, Ekman P, Jahnson S, Lagerkvist M, Lindeborg T, Olsson JL, Tveter K, Wijkstrom H, Westberg R, Malmström PU. Lundholm C, et al. Among authors: jahnson s. J Urol. 1996 Aug;156(2 Pt 1):372-6. doi: 10.1016/s0022-5347(01)65853-1. J Urol. 1996. PMID: 8683682 Clinical Trial.

4

Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy.

Jahnson S, Karlsson MG. Jahnson S, et al. J Urol. 1998 Oct;160(4):1291-6. J Urol. 1998. PMID: 9751338

5

Epidermal growth factor receptor expression: predictive value for the outcome after cystectomy for bladder cancer?

Sriplakich S, Jahnson S, Karlsson MG. Sriplakich S, et al. Among authors: jahnson s. BJU Int. 1999 Mar;83(4):498-503. doi: 10.1046/j.1464-410x.1999.00914.x. BJU Int. 1999. PMID: 10210578

6

Results of second-look resection after primary resection of T1 tumour of the urinary bladder.

Jahnson S, Wiklund F, Duchek M, Mestad O, Rintala E, Hellsten S, Malmström PU. Jahnson S, et al. Scand J Urol Nephrol. 2005;39(3):206-10. doi: 10.1080/00365590510007793-1. Scand J Urol Nephrol. 2005. PMID: 16127800

7

Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancer.

Gårdmark T, Jahnson S, Wahlquist R, Wijkström H, Malmström PU. Gårdmark T, et al. Among authors: jahnson s. BJU Int. 2007 Apr;99(4):817-20. doi: 10.1111/j.1464-410X.2006.06706.x. Epub 2007 Jan 22. BJU Int. 2007. PMID: 17244282 Clinical Trial.

8

Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.

Liedberg F, Anderson H, Bläckberg M, Chebil G, Davidsson T, Gudjonsson S, Jahnson S, Olsson H, Månsson W. Liedberg F, et al. Among authors: jahnson s. Scand J Urol Nephrol. 2007;41(4):290-6. doi: 10.1080/00365590601183576. Scand J Urol Nephrol. 2007. PMID: 17763219

9

A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.

Berrum-Svennung I, Granfors T, Jahnson S, Boman H, Holmäng S. Berrum-Svennung I, et al. Among authors: jahnson s. J Urol. 2008 Jan;179(1):101-5; discussion 105-6. doi: 10.1016/j.juro.2007.08.166. Epub 2007 Nov 12. J Urol. 2008. PMID: 17997459 Clinical Trial.

10

Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.

Jancke G, Damm O, Rosell J, Jahnson S. Jancke G, et al. Among authors: jahnson s. Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302. Scand J Urol Nephrol. 2008. PMID: 18609266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page